- Home
- NOMD vs OGN Comparison
NOMD vs OGN Comparison
Compare NOMD & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOMD
- OGN
- Stock Information
- Founded
- NOMD 2014
- OGN 1923
- Country
- NOMD United Kingdom
- OGN United States
- Employees
- NOMD N/A
- OGN N/A
- Industry
- NOMD Packaged Foods
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- NOMD Consumer Staples
- OGN Health Care
- Exchange
- NOMD Nasdaq
- OGN Nasdaq
- Market Cap
- NOMD 2.6B
- OGN 2.7B
- IPO Year
- NOMD N/A
- OGN N/A
- Fundamental
- Price
- NOMD $12.20
- OGN $9.28
- Analyst Decision
- NOMD Strong Buy
- OGN Buy
- Analyst Count
- NOMD 5
- OGN 3
- Target Price
- NOMD $20.40
- OGN $17.33
- AVG Volume (30 Days)
- NOMD 2.0M
- OGN 3.3M
- Earning Date
- NOMD 11-13-2025
- OGN 10-30-2025
- Dividend Yield
- NOMD 5.56%
- OGN 0.86%
- EPS Growth
- NOMD 6.08
- OGN N/A
- EPS
- NOMD 1.57
- OGN 2.69
- Revenue
- NOMD $3,605,402,231.00
- OGN $6,281,000,000.00
- Revenue This Year
- NOMD $0.78
- OGN N/A
- Revenue Next Year
- NOMD $2.30
- OGN $0.79
- P/E Ratio
- NOMD $7.80
- OGN $3.45
- Revenue Growth
- NOMD 0.29
- OGN N/A
- 52 Week Low
- NOMD $11.86
- OGN $8.01
- 52 Week High
- NOMD $20.81
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- NOMD 33.70
- OGN 33.25
- Support Level
- NOMD $11.86
- OGN $9.41
- Resistance Level
- NOMD $12.46
- OGN $9.72
- Average True Range (ATR)
- NOMD 0.35
- OGN 0.35
- MACD
- NOMD 0.01
- OGN -0.17
- Stochastic Oscillator
- NOMD 19.14
- OGN 5.57
About NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.